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The Evolving Heart Failure Apprenticeship NetworkAnuradha Lala, MD,* Robert J. Mentz, MDy“If everyone is moving forward together,
then success takes care of itself.”
—Henry Ford (1)T he landscape of research in cardiovascularmedicine has changed dramatically from thedays of lone scientists working in secluded
ivory towers. Effective clinical research today thrives
on collaborative efforts that cross institutional and
geographic boundaries. Yet, as early career physicians,
we are so accustomed to trying to stand out from our
colleagues to present, publish, and secure jobs, that
at times it may seem as if there are few opportunities
to achieve academic synergy. Thus, we may miss not
only how fun it is to work together, but also how
much we stand to learn from one another.
Earlier this year in the Journal, Drs. Matthew Tomey
and Tara Naib (2) shared their experience of working in
the American Heart Association Fellows’ Society of
New York, founded by Dr. Valentin Fuster in 1989.
They urged fellows to “build connections beyond
institutional walls” to effect change, build social cap-
ital, and educate. Having been involved in this society,
we bore witness to the infectious energy created when
members united from across 12 local hospitals to
generate new ideas for educational programs, policy-
making, and community service. Individual accom-
plishments represented success for the fellows’
society as a whole. In their eloquent essay, Tomey and
Naib (2) suggest interinstitutional collaboration for the
purposes of clinical research as an essential next step.
The Heart Failure Apprentice Network (HFAN) is
one such organization to have recently developed.
Comprised of heart failure fellows and junior faculty
interested in clinical research careers, and supportedFrom the *Zena and Michael A. Wiener Cardiovascular Institute, Icahn
School of Medicine at Mount Sinai, New York, New York; and the yDuke
Clinical Research Institute, Duke University Medical Center, Durham,
North Carolina. The Heart Failure Apprentice Network is supported by
the following National Heart, Lung, and Blood Institute training grants:
U10 HL110337, U10 HL110262, U10 HL110309, and U10 HL110312.by the National Heart, Lung, and Blood Institute
(NHLBI), HFAN is an ancillary enterprise to the parent
Heart Failure Network (HFN), which is well recog-
nized for conducting clinical trials in heart failure.
Under the apprenticeship of senior Network in-
vestigators, HFAN members engage in a comprehen-
sive clinical research experience that includes 4 key
elements: 1) site-based research as members of a
clinical trial team; 2) development of hypothesis-
based analyses of new trial databases; 3) conception
and launch of prospective pilot studies; and 4) cul-
tivation of a synergistic group-based dynamic to
advance the understanding of heart failure.
SITE-BASED RESEARCH AND SERVING ON A
CLINICAL TRIAL TEAM
As trainees, it is easy to gloss over the methods section
of a paper without considering how much work is
involved in the design and conduct of a clinical
trial. Participation in real-world, site-based research
activities involves protocol development, regulatory
submissions, patient recruitment, data collection,
reporting of adverse effects, and summarizing interim
results for the Data Safety Monitoring Board and Net-
work participants. The ability to organize, perform,
and manage the clinical, scientiﬁc, regulatory, and
ﬁnancial considerations of site-based research re-
quires substantial expertise that is often not appreci-
ated in a classroom setting. Thus, “hands- on” training
by way of actually serving on a multidisciplinary
research team is indispensable in understanding
many of these processes, including the protection of
human subjects, research involving vulnerable pop-
ulations, informed consent, database research, good
clinical practice, and Health Insurance Portability
and Accountability Act regulations. Participation in
steering committee meetings through presenting pro-
posals and data allows us to witness ﬁrsthand the
effective communication, teamwork, and organiza-
tion required to ensure productivity. Observing how
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levels provides additional insight as to how a suc-
cessful clinical research team operates.
DEVELOPMENT OF
HYPOTHESIS-DRIVEN INVESTIGATIONS
As members of HFAN, we are uniquely positioned to
answer clinically relevant questions by interrogating
the Network’s well-characterized trial datasets. Sta-
tistical analysis plans are prepared by HFAN members
in conjunction with a faculty mentor and statistician
and undergo review by an internal ancillary studies
committee. Once data are obtained and requested
analyses are completed by the HFN statistical team,
the HFAN lead author and collaborators drive the
projects to completion by promulgating the ﬁndings
in the form of presentations at national meetings
and scientiﬁc publications (3). Working together to
analyze and interpret data, write scientiﬁc papers, as
well as generate new questions and ideas has affor-
ded opportunities for us to engage with one another
beyond institutional borders.
CONCEPTION AND LAUNCH OF
NEW ANALYSES AND PILOT STUDIES
Although conducting retrospective analyses are
fruitful, we also want to focus our energies on un-
derstanding what questions need to be answered,
rather than what questions can be answered by the
data already collected. Therefore, the development
of prospective investigations as ancillary studies
of proposed Network trials are also strongly encour-
aged. Recently, the HFAN completed RED-ROSE
(Reliable Evaluation of Dyspnea in the ROSE study)
(NCT01132846), an ancillary ROSE-AHF (Renal Opti-
mization Strategies Evaluation–Advanced Heart Fail-
ure) study designed to assess novel symptom
assessment tools in advanced heart failure. Results of
this prospective study were the basis of 2 oral abstract
presentations at the 2014 American College of Cardi-
ology scientiﬁc sessions (4,5), and the manuscripts
are currently under peer review. Collaboration for
such studies is promoted through cross-institutional
visits to share progress and acquire additional re-




Perhaps the most valuable aspect of HFAN has been
discovering what it really means to “play nice in the
sandbox” at this stage in our careers. Several key
lessons have been gleaned along the way:1. Competition for acknowledgment undermines group
cohesion and momentum. The hunger for individual
credit must be replaced with the cultivation of an
environment of shared recognition.
2. Although the group provides structure and inspi-
ration, efﬁciency and progress are contingent upon
an individual or pair of individuals taking primary
responsibility for each project. Roles rotate to allow
every member to enrich his or her skills in the
various aspects of seeing a project to completion:
leadership of calls, meetings, brainstorming, re-
cord keeping, data gathering and analysis, writing,
and presenting, among others.
3. Much like a family, small tensions and disagree-
ments are inevitable. We operate on the assump-
tion that all issues can and will be resolved,
prioritizing group morale, enthusiasm, and effec-
tive conﬂict resolution.
4. At each stage, it is still helpful to have cross-
institutional mentorship to review decisions about
design, style, and authorship to provide constructive
criticism where needed.
MENTORSHIP
Active and involved mentorship is critical for the
development of any successful clinician scientist and
educator. Although mentorship is most commonly
sought at the early career stage, we see this holds true
at all levels, regardless of stature or age. In general,
HFAN stresses a “team mentoring” approach within a
collaborative multidisciplinary atmosphere. A senior
investigator is assigned to each trainee at the time of
entry into the program to guide the trainee’s research
and professional development. This relationship is
supplemented by other individuals with speciﬁc
expertise (e.g., biostatistics or genomics) as needed.
Through processes of clinical trial work, ancillary
studies, data collection, writing, and critiquing,
HFAN affords access to feedback and extramural
mentorship from all of the HFAN advisors, many of
whom are renowned leaders across the United
States. Aside from guidance for speciﬁc tasks and
projects, the counsel received from these seasoned
academic physicians regarding job searches, the
daunting transition from fellow to faculty, and the
struggle of ﬁnding a “work-life balance” is particu-
larly useful.
In today’s challenging economic climate, it is
uplifting to witness the NHLBI’s commitment to the
development of future leaders in HF. Key tangible
metrics of the program include helping trainees
to pursue academic careers, disseminate research,
and obtain grant support. To date, more than 75%
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demic institutions, many with ongoing NIH-funded
research. The group has presented 10 abstracts, with
the majority of these converted into manuscripts,
which are currently under review or published.
Reﬂecting upon our involvement in this remark-
able program over the past 2 years, we are challenged
to deﬁne what success means for us. On a basic level,
success lies in the acquisition of skills in research,
performance, and communication. The larger mea-
sure of success, however, is the establishment of a
cohesive consortium of like-minded individuals
dedicated to the lifelong endeavor of heart failure
research. We have witnessed how much friendship
senior investigators within the Network share, clearly
developed over years of collaboration, and a key part
of what keeps them interested in the ﬁeld. Havinggained so much from working with one another in
such a short time period, we only stand to learn and
grow more in support of each other’s careers as time
goes on. The formation of HFAN called for a shedding
of an acquired sense of competition, replacing it
with a desire for a collaborative collective. If we as
early career physicians can continue to form such
networks whereby the ﬁeld of academic medicine
can be advanced and we all move forward together,
success is bound to “take care of itself.”
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Shared Sacriﬁce and Success
Sean P. Pinney, MD
The Zena andMichael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York
E-mail: sean.pinney@mssm.edu“It is amazing what you can accomplish
if you do not care who gets the credit.”
—Harry S. Truman (1)
It is easy to embrace this simple aphorism of placing the
good of positive action ahead of one’s desire for recogni-
tion. It is much more difﬁcult to put it into motion.
Nevertheless, it appears that the Heart Failure Appren-
ticeship Network (HFAN) is succeeding in doing just that.
In the spirit of collaboration, they have created a collection
of young trialists who view their individual successes as
being subordinate to and intertwined with the success of
the group as a whole. Although this concept of teamwork
is not new to academic medicine, the fact that it has so
rarely been demonstrated bears further exploration.The success of HFAN rests on 5 pillars. The ﬁrst of
these is mentorship, which is generously provided by
experienced academicians who invest their time in
nurturing the careers of future leaders. The second is trust
between the members that in sharing recognition they
will not sacriﬁce their day in the limelight, it will even-
tually come. Third is the belief in a common good, that
through their collective efforts they will be improving the
lives of heart failure patients. Fourth is a thirst for new
knowledge, a quest that drives all curious investigators.
Finally, there is the shared value of hard work, which is a
reward in and of itself.
It is unlikely to be a coincidence that this successful
model of collaboration is emerging at this time. Health
care as a whole, along with its academic circles, are being
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systems place efﬁciencies and outcomes above individual
achievement. Performance metrics and improvement
cycles are replacing some of the romantic images of the
not-so-distant past. Soon academic medicine may lose the
image of the great physician-leader who is the repository
of vast knowledge and who stands head and shoulders
above his or her peers. So, too, may be sacriﬁced the image
of the brilliant lone investigator who toils away in relative
isolation between discoveries. Replacing these iconicimages will be that of a dimensionless network, but so be
it. The results from such collaborations will far exceed that
of any 1 individual.
Having had a chance to work with and interact with
several of the young HFAN members, I can say that the
future looks very bright. Their motivations are no different
than those that drew so many into academic medicine.
These timeless values give shape to our academic land-
scape and ensure that in the future-present of networks,
there will always be a ghost within the machine.RE F E RENCE1. The Quotations page. Available at: http://www.
quotationspage.com/quotes/Harry_S_Truman/.
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